139 related articles for article (PubMed ID: 35117731)
1. PNMA5 knockdown suppresses the proliferation, invasion, and metastasis of epithelial ovarian cancer cells.
Qiao H; Liu J; Yang Z; Gao L; Zhang X; Lu G; Liu Y; Liu M; Ying X; Zhang D
Transl Cancer Res; 2020 May; 9(5):3691-3702. PubMed ID: 35117731
[TBL] [Abstract][Full Text] [Related]
2. Pnma5 is essential to the progression of meiosis in mouse oocytes through a chain of phosphorylation.
Zhang XL; Liu P; Yang ZX; Zhao JJ; Gao LL; Yuan B; Shi LY; Zhou CX; Qiao HF; Liu YH; Ying XY; Zhang JQ; Ling XF; Zhang D
Oncotarget; 2017 Nov; 8(57):96809-96825. PubMed ID: 29228573
[TBL] [Abstract][Full Text] [Related]
3. PNMA5 accelerated cellular proliferation, invasion and migration in colorectal cancer.
Lin J; Zhang X; Meng F; Zeng F; Liu W; He X
Am J Transl Res; 2022; 14(4):2231-2243. PubMed ID: 35559417
[TBL] [Abstract][Full Text] [Related]
4. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
Ma SY; Wei P; Qu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
Ma Z; Wang X; He J; Xia J; Li Y
PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
[TBL] [Abstract][Full Text] [Related]
6. BTG3 Overexpression Suppresses the Proliferation and Invasion in Epithelial Ovarian Cancer Cell by Regulating AKT/GSK3β/β-Catenin Signaling.
An Q; Zhou Y; Han C; Zhou Y; Li F; Li D
Reprod Sci; 2017 Oct; 24(10):1462-1468. PubMed ID: 28183228
[TBL] [Abstract][Full Text] [Related]
7. Exosome Component 4 Promotes Epithelial Ovarian Cancer Cell Proliferation, Migration, and Invasion
Xiong C; Sun Z; Yu J; Lin Y
Front Oncol; 2021; 11():797968. PubMed ID: 34956910
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer.
Yang X; Xu L; Yang YE; Xiong C; Yu J; Wang Y; Lin Y
J Ovarian Res; 2020 Aug; 13(1):100. PubMed ID: 32862831
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of microtubule-associated protein 1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton.
Tang Z; Zhang N; Di W; Li W
Oncol Rep; 2015 Mar; 33(3):1411-7. PubMed ID: 25607473
[TBL] [Abstract][Full Text] [Related]
11. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer.
Wu Y; You Y; Chen L; Liu Y; Liu Y; Lou W; Fu F
Gland Surg; 2022 Apr; 11(4):687-701. PubMed ID: 35531115
[TBL] [Abstract][Full Text] [Related]
12. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression.
Yao N; Sun JQ; Yu L; Ma L; Guo BQ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4642-4649. PubMed ID: 31210289
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway.
Gao J; Liu M; Zou Y; Mao M; Shen T; Zhang C; Song S; Sun M; Zhang S; Wang B; Zhu D; Li P
Oncol Rep; 2015 Dec; 34(6):3212-21. PubMed ID: 26503132
[TBL] [Abstract][Full Text] [Related]
14. Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells.
Wang J; Zheng M; Zhu L; Deng L; Li X; Gao L; Wang C; Wang H; Liu J; Lin B
Cancer Cell Int; 2019; 19():330. PubMed ID: 31827404
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
Zhao J; Liu HR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
[TBL] [Abstract][Full Text] [Related]
16. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
17. High expression of CDC6 is associated with accelerated cell proliferation and poor prognosis of epithelial ovarian cancer.
Deng Y; Jiang L; Wang Y; Xi Q; Zhong J; Liu J; Yang S; Liu R; Wang J; Huang M; Tang C; Su M
Pathol Res Pract; 2016 Apr; 212(4):239-46. PubMed ID: 26920249
[TBL] [Abstract][Full Text] [Related]
18. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.
Dong L; Che H; Li M; Li X
Med Sci Monit; 2016 Sep; 22():3248-56. PubMed ID: 27623016
[TBL] [Abstract][Full Text] [Related]
19. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
[TBL] [Abstract][Full Text] [Related]
20. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
Xu JH; Wang Y; Xu D
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
